P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
Xuan J. Wang(Vanderbilt University), Shaoying Li(Third Affiliated Hospital of Guangzhou Medical University), Carlos E. Bueso‐Ramos(The University of Texas MD Anderson Cancer Center), Yasuhiro Oki(Unknown), Guilin Tang(The University of Texas MD Anderson Cancer Center), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Zhenya Tang(University of Nebraska Medical Center), Nishitha Reddy(Vanderbilt University), Joseph D. Khoury(University of Nebraska Medical Center), L. Jeffrey Medeiros(Delaware Division of Libraries), Sa Wang(The University of Texas MD Anderson Cancer Center), Parth Desai(The University of Texas MD Anderson Cancer Center)
Cited by 92
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Inhibition of JNK activation through NF-κB target genes
|Nature|2001|719